Johnson & Johnson Celebrates Innovation in Novel Drug Delivery Systems with 2023 Dr Paul Janssen Award tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson International (Singapore) Pte. Ltd. announced today at the Singapore Week of Innovation and Technology (SWITCH) the call for participation in the Singapore QuickFire Challenge (QFC), where innovators with the best potential solution will be awarded grant funding from a pool of $100,000 for further development.
ladailypost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ladailypost.com Daily Mail and Mail on Sunday newspapers.
The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson disclosed today that following a review of its portfolio to prioritize the most.